Search Constraints
Search Results
Select an image to start the slideshow
Permethrin pesticide-induced alterations in the dopaminergic system across time points and genders
1 of 17
Socio-environmental Determinants of Post-operative Inpatient Opioid Consumption in Orthopedic Trauma Patients
2 of 17
Antitumor Effects of Progesterone Alone and in Combination with Temozolomide Against Neurogenic Tumors
3 of 17
MDMA's Effect on Myocardial DNA Methylation and its Association with Dilated Cardiomyopathy
4 of 17
Public Health Implications of Emergencies and Disasters
5 of 17
Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCD
6 of 17
Development of a screening assay for vesicular dopamine transport
7 of 17
Exposure to HBCDD - a Brominated Flame Retardant - Induces Altered Synaptic Protein Expression in the Hippocampus and the Frontal Cortex of a Male Mouse Model
8 of 17
Epidemiology of Opportunistic Premise Plumbing Pathogens and
Associated Antibiotic Resistance
9 of 17
The Breathe Easy Telehealth Program: A Project-Based Grant Proposal
Thesis to Improve Asthma Management among Elementary and Middle
School Children in Louisiana
10 of 17
Racial and Ethnic Differences in Poison Center Utilization
11 of 17
Disruption of dopamine circuitry following exposure to the
organochlorine insecticide endosulfan: Implications for
neurological disease
12 of 17
A Descriptive Analysis of Wound Botulism - United States 1999-2014
13 of 17

Using Quantitative Structure-Activity
Relationships (QSAR) to Establish Toxicity/Environmental Scores
(TES)
14 of 17
Pesticides and Parkinson's disease: Attributable Risk of
Occupational Exposure and Neurochemical Analysis of Sub-Chronic
Environmental Exposure
15 of 17
Human Health Effects of Perfluorinated Compounds: Assessing
Exposure in the Alaska Maternal Organic Monitoring Study and
Testing Reproductive Toxicity in a Human Spermatogenesis Stem Cell
Model
16 of 17
Disruption of neuronal circuitry following exposure to chlorinated
organophosphate flame retardants: Implications for neurological
disease
17 of 17